Myeloid Leukemia In Children With Down Syndrome clinical trials

Explore recruiting myeloid leukemia in children with down syndrome clinical trials.

Recruiting myeloid leukemia in children with down syndrome studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Myeloid Leukemia In Children With Down Syndrome trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase III Clinical Trial for CPX-351 in Myeloid Leukemia in Children with Down Syndrome 2018

Germany, Austria, Netherlands, Poland, Belgium, Italy +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Myeloid Leukemia In Children With Down Syndrome trials by city

Myeloid Leukemia In Children With Down Syndrome in Toronto Myeloid Leukemia In Children With Down Syndrome in Vancouver Myeloid Leukemia In Children With Down Syndrome in Montreal Myeloid Leukemia In Children With Down Syndrome in Calgary Myeloid Leukemia In Children With Down Syndrome in Edmonton Myeloid Leukemia In Children With Down Syndrome in Ottawa Myeloid Leukemia In Children With Down Syndrome in Winnipeg Myeloid Leukemia In Children With Down Syndrome in Quebec City Myeloid Leukemia In Children With Down Syndrome in Hamilton Myeloid Leukemia In Children With Down Syndrome in Kitchener Myeloid Leukemia In Children With Down Syndrome in London Myeloid Leukemia In Children With Down Syndrome in Halifax Myeloid Leukemia In Children With Down Syndrome in New York Myeloid Leukemia In Children With Down Syndrome in Los Angeles Myeloid Leukemia In Children With Down Syndrome in Chicago Myeloid Leukemia In Children With Down Syndrome in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease